09639400600

Saturday To Thursday 9 am To 6 pm
butwwbuttw

Weight Loss/Obesity Medications

  Featured
  Specials
  Featured


Creston 10 tablet

Creston 10 tablet

Creston 10 tablet..

Tk.20.00/=

  0 отзывов

Creston 5 tablet

Creston 5 tablet

Creston 5 tablet..

Tk.10.00/=

  0 отзывов

Creva 10mg Tab

Creva 10mg Tab

Creva 10mg Tab..

Tk.27.00/=

  0 отзывов

Creva 5mg Tab

Creva 5mg Tab

Creva 5mg Tab..

Tk.14.00/=

  0 отзывов

Pitavas 2mg Tab

Pitavas 2mg Tab

Pitavas 2mg Tab..

Tk.10.00/=

  0 отзывов

Pivalo 2mg Tablet

Pivalo 2mg Tablet

Indication: Pitavastatin is indicated as an adjunctive therapy to diet to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG) and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia.Dosage & Administration:The dose range for Pitavastatin is 1 to 4 mg orally once daily at any time of the day with or without food. The recommended starting dose is 2 mg and the maximum dose is 4 mg. The starting dose and maintenance doses of Pitavastatin should be individualized according to patient characteristics, such as goal of therapy and response...

Tk.10.03/=

  0 отзывов

Pivalo 4mg Tablet

Pivalo 4mg Tablet

Indication: Pitavastatin is indicated as an adjunctive therapy to diet to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG) and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia.Dosage & Administration:The dose range for Pitavastatin is 1 to 4 mg orally once daily at any time of the day with or without food. The recommended starting dose is 2 mg and the maximum dose is 4 mg. The starting dose and maintenance doses of Pitavastatin should be individualized according to patient characteristics, such as goal of therapy and response...

Tk.18.05/=

  0 отзывов

Pivasta 2 tablet

Pivasta 2 tablet

Pivasta 2 tablet..

Tk.20.00/=

  0 отзывов

Restat 10 Tab

Restat 10 Tab

Restat 10 Tab..

Tk.20.00/=

  0 отзывов

Rocovas 10

Rocovas 10

Rocovas 10 TabDescriptionRosuvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl coenzyme A to mevalonate, a precursor of cholesterol.IndicationsRosuvastatin is indicated for- primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia), mixed dyslipidaemia (type IIb), or homozygousfamilial hypercholesterolaemia in patients who have not responded adequately to diet and other appropriate measures.Dosage & AdministrationDose range: 5-40 mg once daily. Initially 5-10 mg once daily increased if necessary at intervals of at least 4 weeks to 20 mg once daily. Daily dose can be increased after further 4 weeks to 40 mg only in severe hypercholesterolaemia with high cardiovascular risk and under specialist supervision. Elderly initially 5 mg once daily.HoFH: Starting dose 20 mg.In pediatric patients 10 to 17 years of age with HeFH, the usual dose range is 5-20 mg/day; doses greater than 20 mg have not been studied in this patient population.Use 40 mg dose only for patients not reaching LDL-C goal with 20 mgRosuvastatin can be taken with or without food, at any time of day.Side EffectsRosuvastatin is generally well tolerated. The adverse events seen with Rosuvastatin are generally mild and transient. Most commonly occurring side-effects are headache, myalgia, asthenia, constipation, dizziness, nausea, abdominal pain. Uncommonly pruritus, rash and urticaria may occur. Myopathy (including myositis), hypersensitivity reactions (including angioedema), rhabdomyolysis, pancreatitis etc are the rarely occurring side-effects of Rosuvastatin.PrecautionsSkeletal muscle effects (e.g., myopathy and rhabdomyolysis): Risks increase with use of 40 mg dose, advanced age (>65 year), hypothyroidism, renal impairment, and combination use with cyclosporine, lopinavir/ritonavir, atazanavir/ritonavir, or certain other lipid-lowering drugs. Patients should be advised to promptly report unexplained muscle pain, tenderness, or weakness. Rosuvastatin can be discontinued if signs or symptoms appear.Liver enzyme abnormalities and monitoring: Persistent elevations in hepatic transaminases can occur. Liver enzymes should be monitored before and during treatment.Use in Pregnancy & LactationRosuvastatin should be administered to women of childbearing age only when such patients are highly unlikely to conceive and have been informed of the potential hazards. If the patient becomes pregnant while taking this drug, therapy should be discontinued and the patient apprised of the potential hazard to the fetus. Because of the potential for adverse reactions in nursing infants, women taking Rosuvastatin should not breast-feed.Drug InteractionRemarkable drug interactions of Rosuvastatin are-Cyclosporine: Combination increases Rosuvastatin exposure. Rosuvastatin dose should be limited to 5 mg once daily.Gemfibrosil: Combination should be avoided. If used together, Rosuvastatin dose should be limited to 10 mg once daily.Lopinavir/Ritonavir or atazanavir/ritonavir: Combination increases Rosuvastatin exposure. Rosuvastatin dose should be to 10 mg once daily.Coumarin anticoagulants: Combination prolongs international normalized ratio (INR). Stable INR should be achieved prior to starting Rosuvastatin. INR should be monitored frequently until stable upon initiation or alteration of Rosuvastatin therapy.Concomitant lipid-lowering therapies: Use with fibrates and niacin products may increase the risk of skeletal muscle effects.Use in special populationAge and sex: There was no clinically relevant effect of age or sex on the pharmacokinetics of Rosuvastatin in adults.Race: Pharmacokinetic studies show an increase in exposure in Asian subjects compared with Caucasians.Pregnancy and lactation: The safety of rosuvastatin during pregnancy and whilst breast feeding has not been established.Severe renal impairment (not on hemodialysis): Starting dose is 5 mg, not to exceed 10 mgOver DoseThere is no specific treatment in the event of overdose. In the event of overdose, the patient should be treated symptomatically and supportive measures instituted as required. Haemodialysis is unlikely to be of benefit...

Tk.20.00/=

  0 отзывов

Rocovas 20

Rocovas 20

Rocovas 20 tabDescriptionRosuvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl coenzyme A to mevalonate, a precursor of cholesterol.IndicationsRosuvastatin is indicated for- primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia), mixed dyslipidaemia (type IIb), or homozygousfamilial hypercholesterolaemia in patients who have not responded adequately to diet and other appropriate measures.Dosage & AdministrationDose range: 5-40 mg once daily. Initially 5-10 mg once daily increased if necessary at intervals of at least 4 weeks to 20 mg once daily. Daily dose can be increased after further 4 weeks to 40 mg only in severe hypercholesterolaemia with high cardiovascular risk and under specialist supervision. Elderly initially 5 mg once daily.HoFH: Starting dose 20 mg.In pediatric patients 10 to 17 years of age with HeFH, the usual dose range is 5-20 mg/day; doses greater than 20 mg have not been studied in this patient population.Use 40 mg dose only for patients not reaching LDL-C goal with 20 mgRosuvastatin can be taken with or without food, at any time of day.Side EffectsRosuvastatin is generally well tolerated. The adverse events seen with Rosuvastatin are generally mild and transient. Most commonly occurring side-effects are headache, myalgia, asthenia, constipation, dizziness, nausea, abdominal pain. Uncommonly pruritus, rash and urticaria may occur. Myopathy (including myositis), hypersensitivity reactions (including angioedema), rhabdomyolysis, pancreatitis etc are the rarely occurring side-effects of Rosuvastatin.PrecautionsSkeletal muscle effects (e.g., myopathy and rhabdomyolysis): Risks increase with use of 40 mg dose, advanced age (>65 year), hypothyroidism, renal impairment, and combination use with cyclosporine, lopinavir/ritonavir, atazanavir/ritonavir, or certain other lipid-lowering drugs. Patients should be advised to promptly report unexplained muscle pain, tenderness, or weakness. Rosuvastatin can be discontinued if signs or symptoms appear.Liver enzyme abnormalities and monitoring: Persistent elevations in hepatic transaminases can occur. Liver enzymes should be monitored before and during treatment.Use in Pregnancy & LactationRosuvastatin should be administered to women of childbearing age only when such patients are highly unlikely to conceive and have been informed of the potential hazards. If the patient becomes pregnant while taking this drug, therapy should be discontinued and the patient apprised of the potential hazard to the fetus. Because of the potential for adverse reactions in nursing infants, women taking Rosuvastatin should not breast-feed.Drug InteractionRemarkable drug interactions of Rosuvastatin are-Cyclosporine: Combination increases Rosuvastatin exposure. Rosuvastatin dose should be limited to 5 mg once daily.Gemfibrosil: Combination should be avoided. If used together, Rosuvastatin dose should be limited to 10 mg once daily.Lopinavir/Ritonavir or atazanavir/ritonavir: Combination increases Rosuvastatin exposure. Rosuvastatin dose should be to 10 mg once daily.Coumarin anticoagulants: Combination prolongs international normalized ratio (INR). Stable INR should be achieved prior to starting Rosuvastatin. INR should be monitored frequently until stable upon initiation or alteration of Rosuvastatin therapy.Concomitant lipid-lowering therapies: Use with fibrates and niacin products may increase the risk of skeletal muscle effects.Use in special populationAge and sex: There was no clinically relevant effect of age or sex on the pharmacokinetics of Rosuvastatin in adults.Race: Pharmacokinetic studies show an increase in exposure in Asian subjects compared with Caucasians.Pregnancy and lactation: The safety of rosuvastatin during pregnancy and whilst breast feeding has not been established.Severe renal impairment (not on hemodialysis): Starting dose is 5 mg, not to exceed 10 mgOver DoseThere is no specific treatment in the event of overdose. In the event of overdose, the patient should be treated symptomatically and supportive measures instituted as required. Haemodialysis is unlikely to be of benefit...

Tk.30.00/=

  0 отзывов

Rocovas 5

Rocovas 5

Rocovas 5 TabDescriptionRosuvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl coenzyme A to mevalonate, a precursor of cholesterol.IndicationsRosuvastatin is indicated for- primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia), mixed dyslipidaemia (type IIb), or homozygousfamilial hypercholesterolaemia in patients who have not responded adequately to diet and other appropriate measures.Dosage & AdministrationDose range: 5-40 mg once daily. Initially 5-10 mg once daily increased if necessary at intervals of at least 4 weeks to 20 mg once daily. Daily dose can be increased after further 4 weeks to 40 mg only in severe hypercholesterolaemia with high cardiovascular risk and under specialist supervision. Elderly initially 5 mg once daily.HoFH: Starting dose 20 mg.In pediatric patients 10 to 17 years of age with HeFH, the usual dose range is 5-20 mg/day; doses greater than 20 mg have not been studied in this patient population.Use 40 mg dose only for patients not reaching LDL-C goal with 20 mgRosuvastatin can be taken with or without food, at any time of day.Side EffectsRosuvastatin is generally well tolerated. The adverse events seen with Rosuvastatin are generally mild and transient. Most commonly occurring side-effects are headache, myalgia, asthenia, constipation, dizziness, nausea, abdominal pain. Uncommonly pruritus, rash and urticaria may occur. Myopathy (including myositis), hypersensitivity reactions (including angioedema), rhabdomyolysis, pancreatitis etc are the rarely occurring side-effects of Rosuvastatin.PrecautionsSkeletal muscle effects (e.g., myopathy and rhabdomyolysis): Risks increase with use of 40 mg dose, advanced age (>65 year), hypothyroidism, renal impairment, and combination use with cyclosporine, lopinavir/ritonavir, atazanavir/ritonavir, or certain other lipid-lowering drugs. Patients should be advised to promptly report unexplained muscle pain, tenderness, or weakness. Rosuvastatin can be discontinued if signs or symptoms appear.Liver enzyme abnormalities and monitoring: Persistent elevations in hepatic transaminases can occur. Liver enzymes should be monitored before and during treatment.Use in Pregnancy & LactationRosuvastatin should be administered to women of childbearing age only when such patients are highly unlikely to conceive and have been informed of the potential hazards. If the patient becomes pregnant while taking this drug, therapy should be discontinued and the patient apprised of the potential hazard to the fetus. Because of the potential for adverse reactions in nursing infants, women taking Rosuvastatin should not breast-feed.Drug InteractionRemarkable drug interactions of Rosuvastatin are-Cyclosporine: Combination increases Rosuvastatin exposure. Rosuvastatin dose should be limited to 5 mg once daily.Gemfibrosil: Combination should be avoided. If used together, Rosuvastatin dose should be limited to 10 mg once daily.Lopinavir/Ritonavir or atazanavir/ritonavir: Combination increases Rosuvastatin exposure. Rosuvastatin dose should be to 10 mg once daily.Coumarin anticoagulants: Combination prolongs international normalized ratio (INR). Stable INR should be achieved prior to starting Rosuvastatin. INR should be monitored frequently until stable upon initiation or alteration of Rosuvastatin therapy.Concomitant lipid-lowering therapies: Use with fibrates and niacin products may increase the risk of skeletal muscle effects.Use in special populationAge and sex: There was no clinically relevant effect of age or sex on the pharmacokinetics of Rosuvastatin in adults.Race: Pharmacokinetic studies show an increase in exposure in Asian subjects compared with Caucasians.Pregnancy and lactation: The safety of rosuvastatin during pregnancy and whilst breast feeding has not been established.Severe renal impairment (not on hemodialysis): Starting dose is 5 mg, not to exceed 10 mgOver DoseThere is no specific treatment in the event of overdose. In the event of overdose, the patient should be treated symptomatically and supportive measures instituted as required. Haemodialysis is unlikely to be of benefit...

Tk.10.00/=

  0 отзывов

Rolip 10 mg Tab

Rolip 10 mg Tab

Rolip..

Tk.20.00/=

  0 отзывов

Ropitor 10 mg tab

Ropitor 10 mg tab

Ropitor 10 mg tab..

Tk.20.06/=

  0 отзывов

Ropitor 20 mg Tab

Ropitor 20 mg Tab

Ropitor 20 mg Tab..

Tk.30.10/=

  0 отзывов

Ropitor 5 mg tab

Ropitor 5 mg tab

Ropitor 5 mg tab..

Tk.10.03/=

  0 отзывов

Rosetor 10mg tab

Rosetor 10mg tab

Rosetor 10mg tab..

Tk.18.00/=

  0 отзывов

Rosetor 20 Tab

Rosetor 20 Tab

Rosetor 20..

Tk.30.00/=

  0 отзывов

Rosetor 5mg tab

Rosetor 5mg tab

Rosetor 5mg tab..

Tk.10.03/=

  0 отзывов

Rostab 10

Rostab 10

Rostab 10..

Tk.20.07/=

  0 отзывов

Rostab 20

Rostab 20

Rostab 20..

Tk.25.08/=

  0 отзывов

Rostab 5 mg Tab

Rostab 5 mg Tab

Rostab 5 mg Tab..

Tk.10.03/=

  0 отзывов

Rosu 20

Rosu 20

Rosu 20..

Tk.30.00/=

  0 отзывов

Rosu 5

Rosu 5

Rosu 5..

Tk.10.00/=

  0 отзывов

Rosugen 10 Tab

Rosugen 10 Tab

Rosugen 10 Tab..

Tk.20.06/=

  0 отзывов

Rosugen 5 Tab

Rosugen 5 Tab

Rosugen 5 Tab..

Tk.10.03/=

  0 отзывов

rosutin-10mg

Rosutin 10 tablet

rosutin-10mg..

Tk.20.00/=

  0 отзывов

Rosutin 20 mg Tab

Rosutin 20 mg Tab

Rosutin 20 mg Tab..

Tk.30.00/=

  0 отзывов

Rosutin 5 Tablet

Rosutin 5 Tablet

Rosutin 5 Tablet..

Tk.10.00/=

  0 отзывов

Rosuva 10 tablet

Rosuva 10 tablet

Indication: Heterozygous Hypercholesterolemia (Familial and Nonfamilial) Homozygous Hypercholesterolemia (Familial) Mixed Dyslipidemia (Fredrickson Type IIa and IIb)..

Tk.20.13/=

  0 отзывов

Rosuva 20 tablet

Rosuva 20 tablet

Indication: Heterozygous Hypercholesterolemia (Familial and Nonfamilial) Homozygous Hypercholesterolemia (Familial) Mixed Dyslipidemia (Fredrickson Type IIa and IIb)..

Tk.30.10/=

  0 отзывов

Rosuva 5 tablet

Rosuva 5 tablet

Indication: Heterozygous Hypercholesterolemia (Familial and Nonfamilial) Homozygous Hypercholesterolemia (Familial) Mixed Dyslipidemia (Fredrickson Type IIa and IIb)..

Tk.10.03/=

  0 отзывов

Rovast 10mg Tablet

Rovast 10mg Tablet

Rovast 10mg Tablet..

Tk.20.00/=

  0 отзывов

Rovast 5mg Tablet

Rovast 5mg Tablet

Rovast 5mg Tablet..

Tk.10.00/=

  0 отзывов

Rovex 10 Tab

Rovex 10 Tab

Rovex 10 Tab..

Tk.20.00/=

  0 отзывов

Rovex 5 mg Tab

Rovex 5 mg Tab

Rovex 5 mg Tab..

Tk.10.00/=

  0 отзывов

Rozavel 10 Tab

Rozavel 10 Tab

Rozavel 10 Tab..

Tk.25.10/=

  0 отзывов

Rozavel 5 Tab

Rozavel 5 Tab

Rozavel 5 Tab..

Tk.12.54/=

  0 отзывов

Ruvastin 10mg tab

Ruvastin 10mg tab

Ruvastin 10mg tab..

Tk.20.00/=

  0 отзывов

Ruvastin 5mg Tab

Ruvastin 5mg Tab

Ruvastin 5mg Tab..

Tk.10.00/=

  0 отзывов

Showing 1 to 40 of 40 (1 Pages)